dextro-Morphine attenuates the morphine-produced conditioned place preference via the sigma1 receptor activation in the rat

European Journal of Pharmacology

Volumn 562, Issue 3, 2007, Pages 221-226

  Wu, Hsiang en ^a   Schwasinger, Emma T ^a   Terashvili, Maia ^a   Tseng, Leon F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

(Rat); Addiction; Morphine; Opioid; Sigma receptor

Indexed keywords

MORPHINE; MORPHINE SULFATE; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] N METHYL 2 (DIMETHYLAMINO)ETHYLAMINE; OPIATE ANTAGONIST; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REWARD;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLENEDIAMINES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MORPHINE; RATS; RECEPTORS, SIGMA; REWARD; STEREOISOMERISM;

EID: 34147108342     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.083     Document Type: Article

References (44)

1. Bals-Kubik R., Ableitner A., and Shippenberg T.B. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264 (1993) 489-495
2. Calabrese E.J., and Baldwin L.A. Hormesis: the dose-response revolution. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 175-197
3. Carr C.D., Fibinger H.C., and Phillips A.G. Conditioning place preference as a measure of drug reward. In: Liebmanans J.M., and Cooper S.J. (Eds). The Neuropharmacological Basis of Reward (1989), Sci. Publ. Press, Oxford 264-319
4. Chien C.C., and Pasternak G.W. Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid sigma1 system. Eur. J. Pharmacol. 250 (1993) R7-R8
5. Chien C.C., and Pasternak G.W. Selective antagonism of opioid analgesia by a sigma system. J. Pharmacol. Exp. Ther. 271 (1994) 1583-1884
6. Chien C.C., and Pasternak G.W. Sigma antagonists potentiate opioid analgesia in rats. Neurosci. Lett. 190 (1995) 137-139
7. 3H](+)-pentazocine, a highly potent and selective radioligand for sigma receptors. FEBS Lett. 251 (1989) 53-58
8. Diamond D.M., Bennett M.C., Fleshner M., and Rose G.M. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus 2 (1992) 421-430
9. Guitart X., Codony X., and Monroy X. Sigma receptors; biology and therapeutic potential. Psychopharmacology 174 (2004) 301-319
10. Horan B., Gardner E.L., Dewey S.L., Brodie J.D., and Ashby Jr. C.R. The selective sigma 1 receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats. Eur. J. Pharmacol. 426 (2001) R1-R2
11. Iijima I., Minamikawa J.-I., Jacobsen A.E., Brossi A., and Rice K.E. Studies in the (+)-morphinan series-4. A markedly improved synthesis of (+)-morphine. J. Org. Chem. 43 (1978) 1462-1463
12. Jacquet Y.F., Klee W.A., Rice K.C., Iijima I., and Minamikaw J. Stereospecfic and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors?. Science 198 (1977) 842-845
13. Joëls M. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol. Sci. 27 (2006) 244-250
14. Joëls M., and de Kloet E.R. Mineralocorticoid and glucocorticoid receptors in the brain. Implication for ion permeability and transmitter systems. Prog. Neurobiol. 43 (1994) 1-36
15. Liu Y., Chen G.D., Lerner M.R., Brackett D.J., and Matsumoto R.R. Cocaine up-regulates fra-2 and σ-1 receptor gene and protein expression in brain regions involved in addiction and reward. J. Pharmacol. Exp. Ther. 314 (2005) 770-779
16. Marrazzo A., Parenti C., Scavo V., Ronsisvalle S., Scoto G.M., and Ronsisvalle G. In vivo evaluation of (+)-MR200 as a selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia. Life Sci. 78 (2006) 2449-2553
17. 3H]-N-allylnormetazocine bind to different sites in mouse brain. J. Pharmacol. Exp. Ther. 231 (1984) 539-544
18. 1 receptors produce anti-cocaine effects in mice. Eur. J. Pharmacol. 419 (2001) 163-174
19. Matsumoto R.R., McCracken K.A., Pouw B., Zhang Y., and Bowen W.D. Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides. Neuropharmacology 42 (2002) 1042-1055
20. 1 receptor, biochemical and behavioral relevance. Pharmacopsychiatry 37 (2004) S171-S182 (Suppl)
21. 1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res. Rev. 37 (2001) 116-132
22. Maurice T., Martin-Fardon R., Romieu P., and Matsumoto R.R. Sigma1 receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci. Biobehav. Rev. 26 (2002) 499-527
23. 1 receptor in the motivational effects of ethanol in mice. Pharmacol. Biochem. Behav. 74 (2003) 869-876
24. McCracken K.A., Bowen W.D., de Costa B.R., and Matsumoto R.R. Two novel σ receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity. Eur. J. Pharmacol. 370 (1999) 225-232
25. 1 Receptor modulation of opioid analgesia in the mouse. J. Pharmacol. Exp. Ther. 300 (2002) 1070-1074
26. 1 receptor gene associated with alcoholism. Biol. Psychiatry 55 (2004) 85-90
27. Monnet F.P., and Maurice T. The sigma-1 protein as a target for the non-genomic effects of neuro(active)steroid: molecular, physiological and behavioral aspects. J. Pharmacol. Sci. 100 (2006) 93-118
28. Mucha R.F., and Herz A. Preference conditioning produced by opioid active and inactive isomers of levophanol and morphine in rat. Life Sci. 38 (1986) 241-249
29. Neisewander J.L., Pierce R.C., and Bardo M.T. Naloxone enhances the expression of morphine-induced conditioned place preference. Psychopharmacology 100 (1990) 201-205
30. Nguyen E.C., McCracken K.A., Liu Y., Pouw B., and Matsumoto R.R. Involvement of sigma receptor in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology 49 (2005) 638-645
31. Olmstead M.C., and Burns L.H. Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats. Psychopharmacology 12 (2005) 1-6
32. Piepponen T.P., Kivastik T., Katajamaki J., Zharkovsky A., and Ahtee L. Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats. Pharmacol. Biochem. Behav. 58 (1997) 275-279
33. Reddy D.S., and Kulkarni S.K. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res. 791 (1998) 108-116
34. 1 receptor in the cocaine-induced conditioned place preference. NeuroReport 11 (2000) 2885-2888
35. Romieu P., Phan V.L., Martin-Fardon R., and Maurice T. Involvement of the sigma 1 receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Neuropsychopharmacology 26 (2002) 444-455
36. 1) receptor-related neuroactive steroids modulate cocaine-induced reward. J. Neurosci. 23 (2003) 3572-3576
37. Shippenberg T.S., and Heidbreder C. The delta-opioid antagonist naltrindol prevents sensitization to the conditioned rewarding effects of cocaine. Eur. J. Pharmacol. 280 (1995) 55-61
38. Spyraki C. Drug reward studied by use of place conditioning in rats. In: Lades M. (Ed). The Psychopharmacology of Addiction (1988), Oxford Univ. Press, Oxford 97-114
39. Strefanski R., Justinova Z., Hayashi T., Takebayashi M., Goldberg S.R., and Su T.P. Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls. Psychopharmacology 175 (2004) 68-75
40. Suzuki T., Funada M., Narita M., Misawa M., and Nagase H. Pertussis toxin abolishes mu- and delta-opioid agonist-induced place preference. Eur. J. Pharmacol. 205 (1991) 85-88
41. Terashvili M., Wu H., Leitermann R.J., Hung K., Clithero A.D., Schwasinger E.T., and Tseng L.F. Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into posterior nucleus accumbens shell and ventral tegmental area in the rat. J. Pharmacol. Exp. Ther. 309 (2004) 816-824
42. 3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study. Brain Res. 581 (1992) 33-38
43. Wu H., MacDougall R.S., Clithe A.D., Terashvili M., and Tseng L.F. Opposite conditioned place preference responses to endomorphin-1 and endomorphin-2 in the mouse. Neurosci. Lett. 356 (2004) 157-161
44. Wu H., Thompson J., Sun H., Terashvili M., and Tseng L.F. Antianalgesia: stereo-selective action of dextro-morphine over levo-morphine on glia in the mouse spinal cord. J. Pharmacol. Exp. Ther. 314 (2005) 1101-1108